Marine-derived antibacterial peptide FP2606 and use thereof for preparing skin antibacterial drugs

By developing the marine-derived antimicrobial peptide FP2606, the problems of drug resistance and irritation in children's skin antimicrobial products have been solved, providing highly effective and safe antimicrobial drugs and care preparations for children's skin, suitable for industrial production and use on children's skin.

CN122145590APending Publication Date: 2026-06-05CHANGSHA MATERNAL & CHILD HEALTH HOSPITAL

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
CHANGSHA MATERNAL & CHILD HEALTH HOSPITAL
Filing Date
2026-05-07
Publication Date
2026-06-05

Smart Images

  • Figure CN122145590A_ABST
    Figure CN122145590A_ABST
Patent Text Reader

Abstract

The application belongs to the technical field of bioengineering, and relates to a marine-derived antibacterial peptide FP2606 and a use of the marine-derived antibacterial peptide FP2606 in preparation of a skin antibacterial drug. Streptomyces globisporus The application also provides a DNA molecule encoding the antibacterial peptide, a recombinant expression vector and an engineering strain, and realizes high-efficiency heterologous expression of the FP2606 in vitro. Experimental verification shows that the antibacterial peptide FP2606 has strong bacteriostatic activity on common pathogenic bacteria causing skin infection of children, has extremely high biological safety, has no hemolytic activity, no skin cell toxicity and no skin irritation, perfectly adapts to the physiological characteristics of the tender skin of children, and can be widely applied to preparation of a skin external antibacterial preparation for children, a skin infection prevention and treatment drug for children and a skin barrier care product for children.
Need to check novelty before this filing date? Find Prior Art